MEDTIDE(03880),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03880 MEDTIDE

Noon Closed 05-12 11:59:53

22.000

+0.280

+1.29%

High22.200	Low21.700	Vol59.70K
Open21.700	D1 Closing21.720	Amplitude2.30%
Mkt Cap3.12B	Tradable Cap3.12B	Total Shares141.80M
T/O1.31M	T/O Rate0.04%	Tradable Shares141.80M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03880","market":"HK","secType":"STK","nameCN":"MEDTIDE","latestPrice":22,"timestamp":1778558393017,"preClose":21.72,"halted":0,"volume":59700,"delay":0,"changeRate":0.012891344383057144,"floatShares":141800000,"shares":141800000,"eps":1.8784418400739038,"marketStatus":"Noon Closed","change":0.28,"latestTime":"05-12 11:59:53","open":21.7,"high":22.2,"low":21.7,"amount":1310010,"amplitude":0.02302,"askPrice":22,"askSize":5000,"bidPrice":21.82,"bidSize":100,"shortable":0,"etf":0,"ttmEps":1.955653866629089,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1778562000000},"marketStatusCode":3,"adr":0,"listingDate":1751212800000,"exchange":"SEHK","adjPreClose":21.72,"openAndCloseTimeList":[[1778549400000,1778558400000],[1778562000000,1778572800000]],"volumeRatio":1.296289,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03880/wiki","defaultTab":"wiki","newsList":[{"id":"1160432466","title":"Medtide: April 2026 Monthly Return Confirms Unchanged 141.80 Million H-Share Capital and Adequate Public Float","url":"https://stock-news.laohu8.com/highlight/detail?id=1160432466","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160432466?lang=en_us&edition=fundamental","pubTime":"2026-05-06 17:05","pubTimestamp":1778058300,"startTime":"0","endTime":"0","summary":"Medtide Inc. filed its Monthly Return for the period ended 30 April 2026 with Hong Kong Exchanges and Clearing on 6 May 2026, reporting no movements in either authorised or issued share capital. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168795308","title":"MEDTIDE 2025年营收同比增长28.9%，净利大幅提升并完成上市后资本结构优化","url":"https://stock-news.laohu8.com/highlight/detail?id=1168795308","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168795308?lang=en_us&edition=fundamental","pubTime":"2026-04-23 22:47","pubTimestamp":1776955636,"startTime":"0","endTime":"0","summary":"根据MEDTIDE发布的2025年度香港上市公司年报摘要，报告期内公司整体经营表现显著提升，并顺利完成首次公开募股，推动资本结构与业务布局进一步优化。...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"MEDTIDE 2025年营收同比增长28.9%，净利大幅提升并完成上市后资本结构优化","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629853555","title":"Medtide publishes 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2629853555","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629853555?lang=en_us&edition=fundamental","pubTime":"2026-04-23 22:42","pubTimestamp":1776955350,"startTime":"0","endTime":"0","summary":"Medtide released its first ESG report, outlining 2025 performance across governance, product responsibility, workforce, and environmental management.Scope 1 and Scope 2 greenhouse gas emissions totaled 9,518 tCO2e, with emissions intensity at 0.17 tCO2e per RMB 10,000 of revenue.Air emissions metrics showed particulate matter at 0.22 tonnes, with VOC emissions at 0.67 tonnes.Operational risk indicators included zero product recalls for safety or health reasons, with 0 confirmed corruption cases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 23, 2026, and is solely res","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL8nH79j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629719858","title":"Medtide publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2629719858","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629719858?lang=en_us&edition=fundamental","pubTime":"2026-04-23 22:32","pubTimestamp":1776954764,"startTime":"0","endTime":"0","summary":"Medtide released 2025 annual report, highlighting June 2025 Hong Kong listing as key milestone.Full-year performance set new records, supported by stronger demand across integrated peptide CRDMO services.Commercial-scale peptide API capacity expanded in second half, lifting annual output capability to over 1 metric ton with single-batch runs above 50 kg.Project pipeline ended year with 1,614 ongoing programs, including 9 NCE GLP-1 development projects across 7 customers.US Rocklin site buildout advanced, targeting 300 kg annual capacity to support localized GMP peptide API supply.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the Issuer Information S","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL7zvsJg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627297342","title":"Precision Peptide grants 800,000 stock options to consultants at $0.5 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2627297342","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627297342?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:31","pubTimestamp":1776339109,"startTime":"0","endTime":"0","summary":"Precision Peptide Company granted 800,000 stock options to certain consultants under its omnibus long-term incentive plan.Options carry an exercise price of $0.5 per common share.Terms run from one year to three years from grant date.Shares issued on option exercise will be subject to a four-month hold period from grant date.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL5l8fng:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117575956","title":"Medtide Doubles Issued Share Capital to 141.80 Million Shares through Conversion of 68.20 Million Unlisted Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1117575956","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117575956?lang=en_us&edition=fundamental","pubTime":"2026-04-08 18:00","pubTimestamp":1775642459,"startTime":"0","endTime":"0","summary":"Medtide Inc. filed its Monthly Return for Equity Issuer for March 2026, detailing a major capital restructuring that brings all outstanding shares onto The Stock Exchange of Hong Kong (HKEX). Key...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624080539","title":"Medtide (SEHK:3880) Net Margin Surge In 1H FY 2025 Tests Earnings Quality Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2624080539","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624080539?lang=en_us&edition=fundamental","pubTime":"2026-03-31 21:20","pubTimestamp":1774963251,"startTime":"0","endTime":"0","summary":"Medtide (SEHK:3880) has just posted its FY 2025 first half numbers, with revenue of ¥253.8 million and basic EPS of ¥0.82, set against trailing twelve month revenue of ¥570.1 million and EPS of ¥1.63 that sit alongside a reported year over year earnings growth figure of 267.3%. Over recent periods the company has seen revenue move from ¥197.5 million and EPS of ¥0.40 in the first half of FY 2024 to ¥244.8 million and EPS of ¥0.07 in the second half of FY 2024 and then to the latest ¥253.8...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-sehk3880-net-margin-surge-in-1h-fy-2025-tests-earnin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-sehk3880-net-margin-surge-in-1h-fy-2025-tests-earnin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176842672","title":"Medtide 2025 Results: Revenue Reaches RMB570.09 Million, Net Profit Soars 267.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1176842672","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176842672?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:46","pubTimestamp":1774874819,"startTime":"0","endTime":"0","summary":"Medtide Inc. released its audited results for the year ended 31 December 2025. Revenue increased 28.9% year-on-year to RMB570.09 million, driven mainly by strong growth in CDMO services. Net profit...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176147559","title":"Medtide Proposes Articles Revision and Scraps Supervisory Committee in Line with New PRC Company Law","url":"https://stock-news.laohu8.com/highlight/detail?id=1176147559","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176147559?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:46","pubTimestamp":1774874818,"startTime":"0","endTime":"0","summary":"Medtide Inc. (stock short name: MEDTIDE) announced that its Board of Directors resolved on 30 March 2026 to overhaul the company’s governance framework by amending its Articles of Association and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623131044","title":"Medtide proposes bylaw amendments to replace supervisory committee with board audit committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2623131044","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623131044?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:42","pubTimestamp":1774874555,"startTime":"0","endTime":"0","summary":"Medtide set proposed amendments to articles of association for shareholder vote at a forthcoming annual general meeting.Changes would abolish supervisory committee, shifting its functions to board audit committee under revised PRC Company Law effective July 1, 2024.Package also targets stronger shareholder protections, aligning governance rules with updated PRC regulations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL9HRwvH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623912310","title":"Medtide Inc -  Profit for Year RMB217.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2623912310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623912310?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:38","pubTimestamp":1774874282,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nFWN40I0LK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623310914","title":"Medtide FY25 profit jumps to RMB 217 million; revenue rises 28.9% to RMB 570 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623310914","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623310914?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:37","pubTimestamp":1774874272,"startTime":"0","endTime":"0","summary":"Medtide posted profit for the year of RMB 220 million, tripling from a year earlier.Gross margin widened 6.9 percentage points to 63.4%.Listing in June 2025 expanded cash and cash equivalents to RMB 890 million; gearing ratio fell to 12.6%.Capacity expansion in Hangzhou is set to start up in 1Q 2026, lifting total API production capacity to over one metric ton per year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDLCGGyP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153266924","title":"Medtide Inc. (03880) Sets 30 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=1153266924","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153266924?lang=en_us&edition=fundamental","pubTime":"2026-03-16 23:01","pubTimestamp":1773673303,"startTime":"0","endTime":"0","summary":"Medtide Inc. (Stock Code: 03880) has scheduled a board meeting for Monday, 30 March 2026. According to the announcement released on 16 March 2026, the agenda includes: • Reviewing and approving the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619464526","title":"Medtide Inc. schedules board meeting to approve annual results and consider final dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2619464526","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619464526?lang=en_us&edition=fundamental","pubTime":"2026-03-16 22:48","pubTimestamp":1773672499,"startTime":"0","endTime":"0","summary":"Medtide will hold a board meeting on March 30, 2026 to consider and approve its annual results for the year ended December 31, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL1SWGJW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619194292","title":"Pangea Wellness to Rename as The Precision Peptide Company on March 18, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194292","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194292?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:08","pubTimestamp":1773403731,"startTime":"0","endTime":"0","summary":"Pangea said it will change its name to The Precision Peptide Company. The company said its shares are expected to trade on the CSE under the symbol BPC. Pangea also reported a new CUSIP of 74031F104 and a new ISIN of CA74031F1045.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL9ZBhXY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618662443","title":"Medtide Completes Hong Kong-Listed Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2618662443","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618662443?lang=en_us&edition=fundamental","pubTime":"2026-03-09 22:05","pubTimestamp":1773065152,"startTime":"0","endTime":"0","summary":"Medtide (HKG:3880) completed the conversion of 68.2 million unlisted shares into Hong Kong-listed shares on Monday, according to a same-day Hong Kong bourse filing.The listing of the peptide-focused CRDMO's converted shares on the Hong Kong stock exchange will begin at 9:00 am on March 10.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145434260","title":"MEDTIDE Completes Conversion of Domestic Shares to H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1145434260","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145434260?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:10","pubTimestamp":1773058229,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has announced the successful conversion of 68.2011 million non-tradable shares into H shares, which was finalized on March 9, 2026. The converted H shares are scheduled to commence trading on the Stock Exchange of Hong Kong starting at 9:00 a.m. on March 10, 2026.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132041759","title":"MEDTIDE (03880.HK) Completes H-Share Full Circulation; 68.20 Million Domestic Shares Converted, Free Float Rises to 100%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132041759","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132041759?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:03","pubTimestamp":1773057798,"startTime":"0","endTime":"0","summary":"Medtide Inc. (stock code: 03880.HK) announced the completion of its H-share full-circulation programme, converting 68.20 million previously unlisted domestic shares into H shares. Trading in the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162073233","title":"MEDTIDE (03880) Announces February 2026 Monthly Return with No Change in Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1162073233","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162073233?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:22","pubTimestamp":1772616156,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) disclosed its February 2026 monthly return, confirming that the company’s total issued share capital remained at 141.80 million shares. Of these, 73.60 million are H shares and 68.20...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160058425","title":"MEDTIDE's Annual Profit Surge Fails to Impress Amid 50% Stock Plunge","url":"https://stock-news.laohu8.com/highlight/detail?id=1160058425","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160058425?lang=en_us&edition=fundamental","pubTime":"2026-02-28 16:01","pubTimestamp":1772265682,"startTime":"0","endTime":"0","summary":"On February 26, before market opening, MEDTIDE (03880) issued a profit alert for the 2025 fiscal year. According to the announcement, the company anticipates revenue to be between 555 million and 585...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medtideinc.com","stockEarnings":[{"period":"1week","weight":-0.0145},{"period":"1month","weight":-0.0372},{"period":"3month","weight":-0.1581},{"period":"6month","weight":-0.3061},{"period":"1year","weight":-0.2902},{"period":"ytd","weight":-0.2874}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.0198},{"period":"3month","weight":-0.0286},{"period":"6month","weight":-0.0192},{"period":"1year","weight":0.1548},{"period":"ytd","weight":0.0303}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Medtide Inc is a China-based company mainly engaged in the contract research, development and manufacturing of peptide. The Company mainly provides contract research organization (CRO) services, namely peptide new chemical entity (NCE) discovery synthesis, contract development and manufacturing organization (CDMO) services, namely peptide chemistry, manufacturing, and control (CMC) development and commercial manufacturing. The Company's services primarily focus on providing customers with active pharmaceutical ingredients (APIs) rather than drug products. The Company also provides customers with peptide drug development, production, and CMC filing support services. The Company mainly operates its business in the domestic market and overseas markets.","exchange":"SEHK","name":"MEDTIDE","nameEN":"MEDTIDE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MEDTIDE(03880),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MEDTIDE(03880) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MEDTIDE,03880,MEDTIDE股票,MEDTIDE股票老虎,MEDTIDE股票老虎国际,MEDTIDE行情,MEDTIDE股票行情,MEDTIDE股价,MEDTIDE股市,MEDTIDE股票价格,MEDTIDE股票交易,MEDTIDE股票购买,MEDTIDE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MEDTIDE(03880),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MEDTIDE(03880) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}